Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116837792 | 11683779 | 2 | F | 20151231 | 20151029 | 20160713 | PER | US-ROCHE-1610448 | ROCHE | 48.00 | YR | F | Y | 0.00000 | 20160713 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 116837792 | 11683779 | 1 | PS | PERJETA | PERTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 125409 | 840 | MG | ||||||||
| 116837792 | 11683779 | 2 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Intravenous (not otherwise specified) | U | 103792 | 715 | MG | ||||||||
| 116837792 | 11683779 | 3 | SS | TAXOTERE | DOCETAXEL | 1 | Intravenous (not otherwise specified) | Y | 0 | 150 | MG | INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 116837792 | 11683779 | 1 | Breast cancer |
| 116837792 | 11683779 | 2 | Breast cancer |
| 116837792 | 11683779 | 3 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 116837792 | 11683779 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 116837792 | 11683779 | Angioedema | |
| 116837792 | 11683779 | Chest discomfort | |
| 116837792 | 11683779 | Dyspnoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |